中性粒细胞胞外诱捕网与溶栓抵抗:靶向治疗的新见解
这项回顾性观察研究分析了72份血栓切除标本(44份脑动脉、28份冠状动脉),用组织化学和数字定量检测NETs成分。发现脑血栓溶栓后溶解比例显著高于冠状动脉血栓(66% vs 14%,P=0.005),脑血栓H2B表达更高(P=0.031),溶栓与NE阳性升高相关(平均边际效应6.461,95%CI 0.7901-12.13,P=0.02555),血栓年龄是NET含量的唯一独立预测因素(P=0.014)。作者认为现有治疗不改变NET含量,支持研究DNase I等新药。
要点
- 脑血栓与冠状动脉血栓成分不同,脑血栓溶栓后溶解比例显著更高(66% vs 14%,P=0.005)。
- 溶栓与NE阳性升高相关(平均边际效应6.461,95%CI 0.7901-12.13,P=0.02555),与血栓来源无关。
- 血栓年龄是NET含量的唯一独立预测因素(P=0.014),现有治疗不改变NET含量。
核心结论
- 血栓年龄是NET含量的驱动因素,NET含量与不良临床结局相关。
- 目前使用的治疗不改变NET含量。
- 本研究支持研究在溶栓基础上加用新药(如重组人DNase I)以预防NET形成或促进其破坏。
研究设计与样本
- 回顾性观察研究,纳入72份机械取栓后回收的血栓标本,其中44份来自脑动脉、28份来自冠状动脉。
- 标本行苏木精-伊红染色及抗NE抗体、抗组蛋白H2B抗体染色,对NET含量进行组织化学和数字定量。
- 通过单因素和中介分析,将组织学与形态学评估结果与临床信息及介入前治疗进行关联分析。
主要发现
- 脑血栓与冠状动脉血栓成分不同,溶栓后溶解的脑血栓显著多于冠状动脉血栓(66% vs 14%,P=0.005)。
- 脑血栓中NETs表达显著更高,表现为H2B表达更高(P=0.031)。
- 溶栓与更高的NE阳性显著相关(平均边际效应6.461,95%CI 0.7901-12.13,P=0.02555),与血栓来源无关。
- 按血栓位置校正后,抗血小板治疗/肝素使用与H2B/NE含量之间无显著关联。
- 血栓年龄是NET含量的唯一独立预测因素,且不受溶栓治疗中介影响(P=0.014)。
临床怎么用
- 作者认为血栓年龄是NET含量的驱动因素,NET含量与不良临床结局相关。
- 作者指出目前使用的治疗不改变NET含量。
- 作者支持研究在溶栓基础上加用新药(如重组人DNase I)以预防NET形成或促进其破坏。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thrombosis is linked to neutrophil release of neutrophil extracellular traps (NETs). NETs are proposed as a mechanism of resistance to thrombolysis. This study intends to analyze the composition of thrombi retrieved after mechanical thrombectomy, estimate the age and organization of thrombi, and evaluate associations with the use of thrombolysis, antiplatelets, and heparin. METHODS: This retrospective observational study involved 72 samples (44 from cerebral and 28 coronary arteries), which were stained with hematoxylin and eosin, anti-NE (neutrophil elastase) antibody, and anti-histone H2B (histone H2B) antibody, representing different components in NET formation, all detectable during the later stages of NETosis, for histochemical and digital quantification of NET content. The histological and morphological evaluations of the specimens were correlated, through univariate and mediation analyses, with clinical information and therapy administered before intervention. RESULTS: The results demonstrated that the composition of cerebral and coronary thrombi differs, and there were significantly more lytic cerebral thrombi than coronary thrombi (66% versus 14%; P=0.005). There was a considerably higher expression of NETs in the cerebral thrombi as testified by the higher expression of H2B (P=0.031). Thrombolysis was remarkably associated with higher NE positivity (average marginal effect, 6.461 [95% CI, 0.7901-12.13]; P=0.02555), regardless of the origin of thrombi. There was no notable association between the administration of antiaggregant therapy/heparin and H2B/NE amount when adjusted for the thrombus location. Importantly, the age of the thrombus was the only independent predictor of NET content without any mediation of the thrombolytic treatment (P=0.014). CONCLUSIONS: The age of the thrombus is the driving force for NET content, which correlates with impaired clinical outcomes. The therapy that is currently administered does not modify NET content. This study supports the need to investigate new pharmacological approaches added to thrombolysis to prevent NET formation or enhance their disruption, such as recombinant human DNase I (deoxyribonuclease I).
引用
- Mengozzi L, Barison I, Malý M, et al. Neutrophil Extracellular Traps and Thrombolysis Resistance: New Insights for Targeting Therapies. Stroke. 2024. PMID: 38465650. doi:10.1161/STROKEAHA.123.045225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。